Biomimetic HPLC to estimate in vivo behavior of early drug discovery compounds
In this editorial, from Future Drug Discovery, author, Klara L Valko, discuss the use of chromatographic separation in the prediction and characterization of in vivo properties of potential drug compounds.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>